181 related articles for article (PubMed ID: 26517352)
21. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(42):68002-68011. PubMed ID: 27634905
[TBL] [Abstract][Full Text] [Related]
22. The effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysis.
Du H; Guo N; Shi B; Zhang Q; Chen Z; Lu K; Shu Y; Chen T; Zhu L
PLoS One; 2014; 9(5):e96301. PubMed ID: 24787743
[TBL] [Abstract][Full Text] [Related]
23. Mutation HOXB13 c.853delT in Martinican prostate cancer patients.
Marlin R; Créoff M; Merle S; Jean-Marie-Flore M; Rose M; Malsa S; Promeyrat X; Martin F; Comlan G; Rabia N; Taouil T; Issoufaly I; Escarmant P; Vinh-Hung V; Béra O
Prostate; 2020 May; 80(6):463-470. PubMed ID: 32040869
[TBL] [Abstract][Full Text] [Related]
24. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in glutathione S-transferases P1 (GSTP1) Ile105Val and prostate cancer risk: a systematic review and meta-analysis.
Cai Q; Wu T; Zhang W; Guo X; Shang Z; Jiang N; Tian J; Niu Y
Tumour Biol; 2013 Dec; 34(6):3913-22. PubMed ID: 23843029
[TBL] [Abstract][Full Text] [Related]
26. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
27. HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.
Johng D; Torga G; Ewing CM; Jin K; Norris JD; McDonnell DP; Isaacs WB
Prostate; 2019 Mar; 79(4):414-424. PubMed ID: 30560549
[TBL] [Abstract][Full Text] [Related]
28. Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.
Lotan TL; Torres A; Zhang M; Tosoian JJ; Guedes LB; Fedor H; Hicks J; Ewing CM; Isaacs SD; Johng D; De Marzo AM; Isaacs WB
Oncotarget; 2017 Apr; 8(14):22772-22782. PubMed ID: 28186998
[TBL] [Abstract][Full Text] [Related]
29. PLCE1 rs2274223 A>G polymorphism and cancer risk: a meta-analysis.
Umar M; Upadhyay R; Mittal B
Tumour Biol; 2013 Dec; 34(6):3537-44. PubMed ID: 23797815
[TBL] [Abstract][Full Text] [Related]
30. HOXB13 mutations in a population-based, case-control study of prostate cancer.
Stott-Miller M; Karyadi DM; Smith T; Kwon EM; Kolb S; Stanford JL; Ostrander EA
Prostate; 2013 May; 73(6):634-41. PubMed ID: 23129385
[TBL] [Abstract][Full Text] [Related]
31. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.
Yan Y; Liang H; Light M; Li T; Deng Y; Li M; Li S; Qin X
Tumour Biol; 2014 Mar; 35(3):1907-15. PubMed ID: 24101192
[TBL] [Abstract][Full Text] [Related]
32. Quantitative assessment of the associations between CD28 T > C polymorphism (rs3116496) and cancer risk.
Cong J; Zhang S; Gao X
Tumour Biol; 2014 Sep; 35(9):9195-200. PubMed ID: 24927673
[TBL] [Abstract][Full Text] [Related]
33. Association between MPO-463G > A polymorphism and cancer risk: evidence from 60 case-control studies.
Yang WJ; Wang MY; Pan FZ; Shi C; Cen H
World J Surg Oncol; 2017 Aug; 15(1):144. PubMed ID: 28764808
[TBL] [Abstract][Full Text] [Related]
34. Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.
MacInnis RJ; Severi G; Baglietto L; Dowty JG; Jenkins MA; Southey MC; Hopper JL; Giles GG
PLoS One; 2013; 8(2):e54727. PubMed ID: 23457453
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-10 gene -592C>A polymorphism and susceptibility to gastric cancer.
Qi M; Liu DM; Pan LL; Lin YX
Genet Mol Res; 2014 Oct; 13(4):8954-61. PubMed ID: 25366786
[TBL] [Abstract][Full Text] [Related]
36. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
[TBL] [Abstract][Full Text] [Related]
37. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
[TBL] [Abstract][Full Text] [Related]
38. Association between the HSPA1B ±1267A/G polymorphism and cancer risk: a meta-analysis of 14 case-control studies.
Kuang D; Chen W; Song YZ; Yu YY; Zhang DY; Wu L; Tang J
Asian Pac J Cancer Prev; 2014; 15(16):6855-61. PubMed ID: 25169537
[TBL] [Abstract][Full Text] [Related]
39. Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis.
Wei Z; Han G; Bai X
Med Sci Monit; 2015 Jun; 21():1611-6. PubMed ID: 26049557
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness.
Storebjerg TM; Høyer S; Kirkegaard P; Bro F; ; Ørntoft TF; Borre M; Sørensen KD
BJU Int; 2016 Oct; 118(4):646-53. PubMed ID: 26779768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
